Compare BGT & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BGT | AXGN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.3M | 1.7B |
| IPO Year | 2004 | 2013 |
| Metric | BGT | AXGN |
|---|---|---|
| Price | $10.65 | $34.23 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $38.00 |
| AVG Volume (30 Days) | 131.1K | ★ 778.3K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | N/A | $20.60 |
| Revenue Next Year | N/A | $16.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $10.21 | $9.22 |
| 52 Week High | $12.76 | $36.00 |
| Indicator | BGT | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 40.90 | 60.61 |
| Support Level | $10.59 | $30.34 |
| Resistance Level | $10.85 | $36.00 |
| Average True Range (ATR) | 0.16 | 1.36 |
| MACD | 0.02 | 0.32 |
| Stochastic Oscillator | 61.90 | 97.48 |
Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.